164 related articles for article (PubMed ID: 23181981)
61. Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.
Fischer U; Forster M; Rinaldi A; Risch T; Sungalee S; Warnatz HJ; Bornhauser B; Gombert M; Kratsch C; Stütz AM; Sultan M; Tchinda J; Worth CL; Amstislavskiy V; Badarinarayan N; Baruchel A; Bartram T; Basso G; Canpolat C; Cario G; Cavé H; Dakaj D; Delorenzi M; Dobay MP; Eckert C; Ellinghaus E; Eugster S; Frismantas V; Ginzel S; Haas OA; Heidenreich O; Hemmrich-Stanisak G; Hezaveh K; Höll JI; Hornhardt S; Husemann P; Kachroo P; Kratz CP; Te Kronnie G; Marovca B; Niggli F; McHardy AC; Moorman AV; Panzer-Grümayer R; Petersen BS; Raeder B; Ralser M; Rosenstiel P; Schäfer D; Schrappe M; Schreiber S; Schütte M; Stade B; Thiele R; von der Weid N; Vora A; Zaliova M; Zhang L; Zichner T; Zimmermann M; Lehrach H; Borkhardt A; Bourquin JP; Franke A; Korbel JO; Stanulla M; Yaspo ML
Nat Genet; 2015 Sep; 47(9):1020-1029. PubMed ID: 26214592
[TBL] [Abstract][Full Text] [Related]
62. E2A-ZNF384 and NOL1-E2A fusion created by a cryptic t(12;19)(p13.3; p13.3) in acute leukemia.
Zhong CH; Prima V; Liang X; Frye C; McGavran L; Meltesen L; Wei Q; Boomer T; Varella-Garcia M; Gump J; Hunger SP
Leukemia; 2008 Apr; 22(4):723-9. PubMed ID: 18185522
[TBL] [Abstract][Full Text] [Related]
63. Pediatric acute lymphoblastic leukemia with t(1;19)/TCF3-PBX1 in Taiwan.
Yen HJ; Chen SH; Chang TY; Yang CP; Lin DT; Hung IJ; Lin KH; Chen JS; Hsiao CC; Chang TT; Chang TK; Peng CT; Lin MT; Jaing TH; Liu HC; Jou ST; Lu MY; Cheng CN; Sheen JM; Chiou SS; Hung GY; Wu KH; Yeh TC; Wang SC; Chen RL; Chang HH; Yang YL; Chen SH; Cheng SN; Chang YH; Chen BW; Hsieh YL; Huang FL; Ho WL; Wang JL; Chang CY; Chao YH; Lin PC; Chen YC; Liao YM; Lin TH; Shih LY; Liang DC
Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28436581
[TBL] [Abstract][Full Text] [Related]
64. Characterization of TCF3 rearrangements in pediatric B-lymphoblastic leukemia/lymphoma by mate-pair sequencing (MPseq) identifies complex genomic rearrangements and a novel TCF3/TEF gene fusion.
Rowsey RA; Smoley SA; Williamson CM; Vasmatzis G; Smadbeck JB; Ning Y; Greipp PT; Hoppman NL; Baughn LB; Ketterling RP; Peterson JF
Blood Cancer J; 2019 Oct; 9(10):81. PubMed ID: 31575852
[TBL] [Abstract][Full Text] [Related]
65. RUNX1-PDCD6 fusion resulting from a novel t(5;21)(p15;q22) chromosome translocation in myelodysplastic syndrome secondary to chronic lymphocytic leukemia.
Panagopoulos I; Gorunova L; Jacobsen EM; Andersen K; Micci F; Heim S
PLoS One; 2018; 13(4):e0196181. PubMed ID: 29672642
[TBL] [Abstract][Full Text] [Related]
66. t(12;17)(p13;q12)/TAF15-ZNF384 Rearrangement in Acute Lymphoblastic Leukemia.
Kim J; Kim HS; Shin S; Lee ST; Choi JR
Ann Lab Med; 2016 Jul; 36(4):396-8. PubMed ID: 27139620
[No Abstract] [Full Text] [Related]
67. A subtle deletion of 12p by routine cytogenetics is found to be a translocation to 21q by fluorescence in situ hybridization: t(12;21)(p13;q22).
Filatov LV; Saito M; Behm FG; Rivera GK; Raimondi SC
Cancer Genet Cytogenet; 1996 Jul; 89(2):136-40. PubMed ID: 8697420
[TBL] [Abstract][Full Text] [Related]
68. Up-regulation of survivin by the E2A-HLF chimera is indispensable for the survival of t(17;19)-positive leukemia cells.
Okuya M; Kurosawa H; Kikuchi J; Furukawa Y; Matsui H; Aki D; Matsunaga T; Inukai T; Goto H; Altura RA; Sugita K; Arisaka O; Look AT; Inaba T
J Biol Chem; 2010 Jan; 285(3):1850-60. PubMed ID: 19887369
[TBL] [Abstract][Full Text] [Related]
69. Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapy.
Watanabe A; Inukai T; Kagami K; Abe M; Takagi M; Fukushima T; Fukushima H; Nanmoku T; Terui K; Ito T; Toki T; Ito E; Fujimura J; Goto H; Endo M; Look T; Kamps M; Minegishi M; Takita J; Inaba T; Takahashi H; Ohara A; Harama D; Shinohara T; Somazu S; Oshiro H; Akahane K; Goi K; Sugita K
Cancer Med; 2019 Sep; 8(11):5274-5288. PubMed ID: 31305009
[TBL] [Abstract][Full Text] [Related]
70. RNA sequencing identifies fusion of the EWSR1 and YY1 genes in mesothelioma with t(14;22)(q32;q12).
Panagopoulos I; Thorsen J; Gorunova L; Micci F; Haugom L; Davidson B; Heim S
Genes Chromosomes Cancer; 2013 Aug; 52(8):733-40. PubMed ID: 23630070
[TBL] [Abstract][Full Text] [Related]
71. BCR-PDGFRA fusion in a T lymphoblastic leukemia/lymphoma.
Yigit N; Wu WW; Subramaniyam S; Mathew S; Geyer JT
Cancer Genet; 2015; 208(7-8):404-7. PubMed ID: 26095243
[TBL] [Abstract][Full Text] [Related]
72. [A clinical and laboratory study of TCF3-PBX1 positive adult acute lymphoblastic leukemia.].
Zheng JF; Qiu HY; Pan JL; Cen JN; Wu YF; Zhang J; Wu DP; Xue YQ
Zhonghua Xue Ye Xue Za Zhi; 2010 Jan; 31(1):16-20. PubMed ID: 20302770
[TBL] [Abstract][Full Text] [Related]
73. MLL/ENL fusion in congenital acute lymphoblastic leukemia with a unique t(11;18;19).
Horstmann M; Argyriou-Tirita A; Borkhardt A; Kabisch H; Kapaun P; Winkler K; Haas OA
Cancer Genet Cytogenet; 1996 Jun; 88(2):103-9. PubMed ID: 8640717
[TBL] [Abstract][Full Text] [Related]
74. TLS/FUS-ERG fusion gene in acute lymphoblastic leukemia with t(16;21)(p11;q22) and monitoring of minimal residual disease.
Kanazawa T; Ogawa C; Taketani T; Taki T; Hayashi Y; Morikawa A
Leuk Lymphoma; 2005 Dec; 46(12):1833-5. PubMed ID: 16263589
[TBL] [Abstract][Full Text] [Related]
75. Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma.
Thompson-Wicking K; Francis RW; Stirnweiss A; Ferrari E; Welch MD; Baker E; Murch AR; Gout AM; Carter KW; Charles AK; Phillips MB; Kees UR; Beesley AH
Oncogene; 2013 Sep; 32(39):4664-74. PubMed ID: 23128391
[TBL] [Abstract][Full Text] [Related]
76. Translocation t(1;19)(q23;p13) in adult acute lymphoblastic leukemia - a distinct subtype with favorable prognosis.
Yilmaz M; Kantarjian HM; Toruner G; Yin CC; Kanagal-Shamanna R; Cortes JE; Issa G; Short NJ; Khoury JD; Garcia-Manero G; Ravandi F; Kadia T; Konopleva M; Wierda WG; Jain N; Estrov Z; Sasaki K; Pierce S; O'Brien SM; Jabbour EJ
Leuk Lymphoma; 2021 Jan; 62(1):224-228. PubMed ID: 32955970
[TBL] [Abstract][Full Text] [Related]
77. Expression of a novel type of KMT2A/EPS15 fusion transcript in FLT3 mutation-positive B-lymphoblastic leukemia with t(1;11)(p32;q23).
Yamamoto K; Yakushijin K; Mizutani Y; Okuni-Watanabe M; Goto H; Higashime A; Miyata Y; Kitao A; Matsumoto H; Saegusa J; Matsuoka H; Minami H
Cancer Genet; 2021 Jun; 254-255():92-97. PubMed ID: 33647817
[TBL] [Abstract][Full Text] [Related]
78. Expression of two types of E2A-HLF fusion proteins in YCUB-2, a novel cell line established from B-lineage leukemia with t(17;19).
Takahashi H; Goto H; Eunabiki T; Fujii H; Yamazaki S; Fujioka K; Ikuta K; Kai S
Leukemia; 2001 Jun; 15(6):995-7. PubMed ID: 11417493
[No Abstract] [Full Text] [Related]
79. Partial 17q gain resulting from isochromosomes, unbalanced translocations and complex rearrangements is associated with gene overexpression, older age and shorter overall survival in high hyperdiploid childhood acute lymphoblastic leukemia.
Herou E; Biloglav A; Johansson B; Paulsson K
Leukemia; 2013 Feb; 27(2):493-6. PubMed ID: 22801382
[No Abstract] [Full Text] [Related]
80. Clonal evolution in adult TCF3::HLF-positive acute lymphoblastic leukemia undergoing stem cell transplantation.
Ahmed MZ; Venkatadasari I; Dyer S; Wall K; Huxley E; Lovell R; Kishore B; Dassanayake H; Francis S; Nikolousis E; Kanellopoulos A
Ann Hematol; 2022 Nov; 101(11):2553-2554. PubMed ID: 35907039
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
